Internal Medicine, Rheumatology · Boston, MA
NPI
1295770386
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
725 Albany Street, Suite 8a, Shapiro Bldg
Boston, MA, 02118
Phone (617) 638-7460
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
521 services
Medicare patients, 2024
148
Average age 73
Drug cost, 2024
$4.5M
2,271 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eugene Y Kissin was code 99214 (office e&m - established), 213 times for 89 patients. In total Eugene Y Kissin billed 521 services in 22 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 213 | 89 | $72.98 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 105 | 68 | $13.43 | $1,410 |
| 99213 Office E&M - Established | Facility | 85 | 59 | $50.19 | $4,266 |
| 20611 Joint Injection | Facility | 30 | 24 | $48.20 | $1,446 |
| 20610 Joint Injection | Facility | 24 | 16 | $39.74 | $954 |
| 99204 Office E&M - New | Facility | 12 | 12 | $104.45 | $1,253 |
By year: 2022 $33K for 520 services; 2023 $29K for 456 services; 2024 $28K for 521 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eugene Y Kissin prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 268 prescriptions and refills. In total Eugene Y Kissin wrote 2,271 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 268 | 386 | 53 | $5,486 |
| Hydroxychloroquine Sulfate Generic | 250 | 334 | 46 | $8,789 |
| Allopurinol Generic | 114 | 272 | 32 | $1,446 |
| Prednisone Generic | 111 | 150 | 33 | $751 |
| Enbrel Sureclick Etanercept | 109 | 115 | 17 | $754K |
| Diclofenac Sodium Generic | 93 | 105 | 37 | $2,677 |
| Colchicine Generic | 74 | 122 | 16 | $5,432 |
| Xeljanz Xr Tofacitinib Citrate | 70 | 70 | Under 11 | $394K |
| Leflunomide Generic | 69 | 103 | 15 | $3,682 |
| Alendronate Sodium Generic | 63 | 113 | 16 | $286 |
| Rasuvo Methotrexate/Pf | 60 | 78 | Under 11 | $42K |
| Humira Pen Adalimumab | 57 | 57 | Under 11 | $376K |
| Kevzara Sarilumab | 57 | 57 | Under 11 | $237K |
| Leucovorin Calcium Generic | 54 | 91 | Under 11 | $1,377 |
| Taltz Autoinjector Ixekizumab | 51 | 57 | Under 11 | $453K |
Brand drugs: - claims; generic drugs: 1,459 claims; opioid claims: 26.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Eugene Y Kissin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.